1. Buccal dextrose gel should be considered as part of a strategy for managing asymptomatic neonates with low glucose concentrations. |
2. For asymptomatic neonates with low glucose concentrations requiring intravenous dextrose, bolus glucose infusions may be replaced by simply starting the patient on a continuous dextrose infusion. |
3. Continuous glucose monitoring should be considered in research protocols to assess the benefits and risks of different glycemic patterns for outcomes. |